.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Predict branded drug patent expiration
  • Identify first generic entrants

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Boehringer Ingelheim
Daiichi Sankyo
Merck
Chinese Patent Office
Fish and Richardson
Healthtrust
Citi
Teva
Novartis

Generated: June 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021143

« Back to Dashboard
NDA 021143 describes TRIVAGIZOLE 3, which is a drug marketed by Taro and is included in one NDA. It is available from nine suppliers. Additional details are available on the TRIVAGIZOLE 3 profile page.

The generic ingredient in TRIVAGIZOLE 3 is clotrimazole. There are eleven drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the clotrimazole profile page.

Summary for NDA: 021143

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antifungals
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 021143

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TRIVAGIZOLE 3
clotrimazole
CREAM;VAGINAL 021143 NDA Walgreen Company 0363-2062 0363-2062-01 1 TUBE, WITH APPLICATOR in 1 CARTON (0363-2062-01) > 21 g in 1 TUBE, WITH APPLICATOR
TRIVAGIZOLE 3
clotrimazole
CREAM;VAGINAL 021143 NDA MSD Consumer Care, Inc. 11523-0771 11523-0771-1 1 TUBE, WITH APPLICATOR in 1 CARTON (11523-0771-1) > 21 g in 1 TUBE, WITH APPLICATOR

Summary for product number 001

Active Rx/OTC/Discontinued:OTCDosage:CREAM;VAGINALStrength2%
Approval Date:Apr 12, 2000TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Johnson and Johnson
Colorcon
US Army
Daiichi Sankyo
Mallinckrodt
Moodys
UBS
Chubb
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot